Articles by P. K Isogai (2)

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

N Mittmann, H. J Au, D Tu, C. J O'Callaghan, P. K Isogai, C. S Karapetis, J. R Zalcberg, W. K Evans, M. J Moore, J Siddiqui, B Findlay, B Colwell, J Simes, P Gibbs, M Links, N. C Tebbutt, D. J Jonker and Working Group on Economic Analysis of the National Cancer Institute of Canada Clinical Trials GroupA

JNCI J Natl Cancer Inst 101 ( 17 ): 1182 - 1192 , 2009

Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer

P. A Bradbury, D Tu, L Seymour, P. K Isogai, L Zhu, R Ng, N Mittmann, M. S Tsao, W. K Evans, F. A Shepherd, N. B Leighl and on behalf of the NCIC Clinical Trials Group Working Group on Economic Analysis

JNCI J Natl Cancer Inst 102 ( 5 ): 298 - 306 , 2010

Do you have a suggestion for journals

Suggest Journal